Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

[Tuberculosis: from compulsory admission to compulsory treatment].

Drijver-Messelink MT, Kerstjens HAM, de Lange WCM, de Vries J, van der Werf TS, Akkerman OW.

Ned Tijdschr Geneeskd. 2018 Aug 3;162. pii: D2439. Dutch.

PMID:
30182637
2.

Effects of Shared Decision Making on Distress and Health Care Utilization Among Patients With Lung Cancer: A Systematic Review.

Geerse OP, Stegmann ME, Kerstjens HAM, Hiltermann TJN, Bakitas M, Zimmermann C, Deal AM, Brandenbarg D, Berger MY, Berendsen AJ.

J Pain Symptom Manage. 2018 Aug 24. pii: S0885-3924(18)30441-X. doi: 10.1016/j.jpainsymman.2018.08.011. [Epub ahead of print] Review.

PMID:
30145213
3.

Chartis Measurement of Collateral Ventilation: Conscious Sedation versus General Anesthesia - A Retrospective Comparison.

Welling JBA, Hartman JE, Ten Hacken NHT, Franz I, Charbonnier JP, van Rikxoort EM, Kerstjens HAM, Klooster K, Slebos DJ.

Respiration. 2018 Aug 16:1-8. doi: 10.1159/000490733. [Epub ahead of print]

4.

Giants in Chest Medicine: Dirkje S. Postma, MD, PhD.

Kerstjens HAM.

Chest. 2018 Jun;153(6):1296-1298. doi: 10.1016/j.chest.2018.03.002. No abstract available.

PMID:
29884249
5.

Aging-related trajectories of lung function in the general population-The Doetinchem Cohort Study.

van Oostrom SH, Engelfriet PM, Verschuren WMM, Schipper M, Wouters IM, Boezen M, Smit HA, Kerstjens HAM, Picavet HSJ.

PLoS One. 2018 May 16;13(5):e0197250. doi: 10.1371/journal.pone.0197250. eCollection 2018.

6.

Predictive value of eosinophils and neutrophils on clinical effects of ICS in COPD.

Hartjes FJ, Vonk JM, Faiz A, Hiemstra PS, Lapperre TS, Kerstjens HAM, Postma DS, van den Berge M; and the Groningen and Leiden Universities Corticosteroids in Obstructive Lung Disease (GLUCOLD) Study Group.

Respirology. 2018 Nov;23(11):1023-1031. doi: 10.1111/resp.13312. Epub 2018 Apr 26.

7.

Nasal epithelium as a proxy for bronchial epithelium for smoking-induced gene expression and expression Quantitative Trait Loci.

Imkamp K, Berg M, Vermeulen CJ, Heijink IH, Guryev V, Kerstjens HAM, Koppelman GH, van den Berge M, Faiz A.

J Allergy Clin Immunol. 2018 Jul;142(1):314-317.e15. doi: 10.1016/j.jaci.2018.01.047. Epub 2018 Mar 6. No abstract available.

PMID:
29522853
8.

Correction: Variability and cost implications of three generations of the Roche LightCycler® 480.

Dullaert-de Boer M, Akkerman OW, Vermeer M, Hess DLJ, Kerstjens HAM, Anthony RM, van der Werf TS, van Soolingen D, van der Zanden AGM.

PLoS One. 2018 Feb 9;13(2):e0192946. doi: 10.1371/journal.pone.0192946. eCollection 2018.

9.

Cross border, highly individualised treatment of a patient with challenging extensively drug-resistant tuberculosis.

Akkerman OW, Grasmeijer F, de Lange WCM, Kerstjens HAM, de Vries G, Bolhuis MS, Alffenaar JW, Frijlink HW, Smith G, Gajraj R, de Zwaan R, Hagedoorn P, Dedicoat M, van Soolingen D, van der Werf TS.

Eur Respir J. 2018 Mar 22;51(3). pii: 1702490. doi: 10.1183/13993003.02490-2017. Print 2018 Mar. No abstract available.

10.

Efficacy of tiotropium in adults with moderate asthma, by leukotriene receptor antagonist use at baseline.

Hashimoto S, Casale TB, Engel M, Moroni-Zentgraf P, Bour LJ, Kerstjens HAM.

Allergol Int. 2018 Jul;67(3):411-413. doi: 10.1016/j.alit.2017.12.002. Epub 2018 Feb 15. No abstract available.

11.

Variability and cost implications of three generations of the Roche LightCycler® 480.

Dullaert-de Boer M, Akkerman OW, Vermeer M, Hess DLJ, Kerstjens HAM, Anthony RM, van der Werf TS, van Soolingen D, van der Zanden AGM.

PLoS One. 2018 Jan 12;13(1):e0190847. doi: 10.1371/journal.pone.0190847. eCollection 2018. Erratum in: PLoS One. 2018 Feb 9;13(2):e0192946.

12.

Nasal gene expression differentiates COPD from controls and overlaps bronchial gene expression.

Boudewijn IM, Faiz A, Steiling K, van der Wiel E, Telenga ED, Hoonhorst SJM, Ten Hacken NHT, Brandsma CA, Kerstjens HAM, Timens W, Heijink IH, Jonker MR, de Bruin HG, Sebastiaan Vroegop J, Pasma HR, Boersma WG, Wielders P, van den Elshout F, Mansour K, Spira A, Lenburg ME, Guryev V, Postma DS, van den Berge M.

Respir Res. 2017 Dec 21;18(1):213. doi: 10.1186/s12931-017-0696-5.

13.

Extrafine compared to non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma.

Cox CA, Boudewijn IM, Vroegop SJ, Schokker S, Lexmond AJ, Frijlink HW, Hagedoorn P, Vonk JM, Farenhorst MP, Ten Hacken NHT, Kerstjens HAM, Postma DS, van den Berge M.

Respir Med. 2017 Sep;130:35-42. doi: 10.1016/j.rmed.2017.07.005. Epub 2017 Jul 8.

PMID:
29206631
14.

Cardiovascular effects of oral appliance therapy in obstructive sleep apnea: A systematic review and meta-analysis.

de Vries GE, Wijkstra PJ, Houwerzijl EJ, Kerstjens HAM, Hoekema A.

Sleep Med Rev. 2018 Aug;40:55-68. doi: 10.1016/j.smrv.2017.10.004. Epub 2017 Oct 26. Review.

PMID:
29195726
15.

Tiotropium Respimat Add-on Is Efficacious in Symptomatic Asthma, Independent of T2 Phenotype.

Casale TB, Bateman ED, Vandewalker M, Virchow JC, Schmidt H, Engel M, Moroni-Zentgraf P, Kerstjens HAM.

J Allergy Clin Immunol Pract. 2018 May - Jun;6(3):923-935.e9. doi: 10.1016/j.jaip.2017.08.037. Epub 2017 Nov 22.

16.

Minimal important difference of target lobar volume reduction after endobronchial valve treatment for emphysema.

Welling JBA, Hartman JE, van Rikxoort EM, Ten Hacken NHT, Kerstjens HAM, Klooster K, Slebos DJ.

Respirology. 2018 Mar;23(3):306-310. doi: 10.1111/resp.13178. Epub 2017 Sep 15.

PMID:
28913877
17.

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease.

Pavord ID, Chanez P, Criner GJ, Kerstjens HAM, Korn S, Lugogo N, Martinot JB, Sagara H, Albers FC, Bradford ES, Harris SS, Mayer B, Rubin DB, Yancey SW, Sciurba FC.

N Engl J Med. 2017 Oct 26;377(17):1613-1629. doi: 10.1056/NEJMoa1708208. Epub 2017 Sep 11.

18.

Assessment of Burden of COPD tool: evidence not perception.

Slok AHM, Kotz D, van Breukelen G, Chavannes NH, Rutten-van Mölken MPMH, Kerstjens HAM, van der Molen T, Asijee GM, Dekhuijzen PNR, Holverda S, Salomé PL, Goossens LMA, Twellaar M, In 't Veen JCCM, van Schayck OCP.

Eur Respir J. 2017 Jul 27;50(1). pii: 1700756. doi: 10.1183/13993003.00756-2017. Print 2017 Jul. No abstract available.

PMID:
28751417
19.

Pleural Adhesion Assessment as a Predictor for Pneumothorax after Endobronchial Valve Treatment.

van Geffen WH, Klooster K, Hartman JE, Ten Hacken NHT, Kerstjens HAM, Wolf RFE, Slebos DJ.

Respiration. 2017;94(2):224-231. doi: 10.1159/000477258. Epub 2017 Jun 22.

20.

Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids.

Kunz LIZ, Ten Hacken NH, Lapperre TS, Timens W, Kerstjens HAM, van Schadewijk A, Vonk JM, Sont JK, Snoeck-Stroband JB, Postma DS, Sterk PJ, Hiemstra PS; GLUCOLD Study Group.

Eur Respir J. 2017 Jun 15;49(6). pii: 1700848. doi: 10.1183/13993003.00848-2017. Print 2017 Jun. No abstract available.

PMID:
28619964
21.

Emerging bronchoscopic treatments for chronic obstructive pulmonary disease.

van Geffen WH, Kerstjens HAM, Slebos DJ.

Pharmacol Ther. 2017 Nov;179:96-101. doi: 10.1016/j.pharmthera.2017.05.007. Epub 2017 May 18. Review.

22.

Pharmacokinetics of moxifloxacin and linezolid during and after pregnancy in a patient with multidrug-resistant tuberculosis.

Van Kampenhout E, Bolhuis MS, Alffenaar JC, Oswald LM, Kerstjens HA, de Lange WC, van der Werf TS, Akkerman OW.

Eur Respir J. 2017 Mar 22;49(3). pii: 1601724. doi: 10.1183/13993003.01724-2016. Print 2017 Mar. No abstract available.

23.

Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids.

Kunz LI, Ten Hacken NH, Lapperre TS, Timens W, Kerstjens HA, van Schadewijk A, Vonk JM, Sont JK, Snoeck-Stroband JB, Postma DS, Sterk PJ, Hiemstra PS; GLUCOLD Study Group.

Eur Respir J. 2017 Jan 3;49(1). pii: 1600839. doi: 10.1183/13993003.00839-2016. Print 2017 Jan.

24.

Pharmacokinetics of tiotropium administered by Respimat® in asthma patients: Analysis of pooled data from Phase II and III clinical trials.

Sharma A, Kerstjens HA, Aalbers R, Moroni-Zentgraf P, Weber B, Dahl R.

Pulm Pharmacol Ther. 2017 Feb;42:25-32. doi: 10.1016/j.pupt.2016.12.003. Epub 2016 Dec 28.

PMID:
28039077
25.

Stable State Proadrenomedullin Level in COPD Patients: A Validation Study.

Zuur-Telgen M, VanderValk P, van der Palen J, Kerstjens HA, Brusse-Keizer M.

COPD. 2017 Apr;14(2):219-227. doi: 10.1080/15412555.2016.1250254. Epub 2016 Nov 23.

PMID:
27880050
26.

Shorter treatment for multidrug-resistant tuberculosis: the good, the bad and the ugly.

van Altena R, Akkerman OW, Alffenaar JC, Kerstjens HA, Magis-Escurra C, Boeree MJ, van Soolingen D, de Lange WC, Bolhuis MS, Hoefsloot W, de Vries G, van der Werf TS.

Eur Respir J. 2016 Dec;48(6):1800-1802. doi: 10.1183/13993003.01208-2016. Epub 2016 Oct 6. No abstract available.

27.

Increased neutrophil expression of pattern recognition receptors during COPD exacerbations.

Pouwels SD, van Geffen WH, Jonker MR, Kerstjens HA, Nawijn MC, Heijink IH.

Respirology. 2017 Feb;22(2):401-404. doi: 10.1111/resp.12912. Epub 2016 Sep 27.

PMID:
27679416
28.

Safety and tolerability of once-daily tiotropium Respimat(®) as add-on to at least inhaled corticosteroids in adult patients with symptomatic asthma: A pooled safety analysis.

Dahl R, Engel M, Dusser D, Halpin D, Kerstjens HAM, Zaremba-Pechmann L, Moroni-Zentgraf P, Busse WW, Bateman ED.

Respir Med. 2016 Sep;118:102-111. doi: 10.1016/j.rmed.2016.07.001. Epub 2016 Jul 2.

29.

Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD.

van Geffen WH, Douma WR, Slebos DJ, Kerstjens HA.

Cochrane Database Syst Rev. 2016 Aug 29;(8):CD011826. doi: 10.1002/14651858.CD011826.pub2. Review.

PMID:
27569680
30.

Tiotropium improves lung function, exacerbation rate, and asthma control, independent of baseline characteristics including age, degree of airway obstruction, and allergic status.

Kerstjens HA, Moroni-Zentgraf P, Tashkin DP, Dahl R, Paggiaro P, Vandewalker M, Schmidt H, Engel M, Bateman ED.

Respir Med. 2016 Aug;117:198-206. doi: 10.1016/j.rmed.2016.06.013. Epub 2016 Jun 14.

31.

Effectiveness of the Assessment of Burden of COPD (ABC) tool on health-related quality of life in patients with COPD: a cluster randomised controlled trial in primary and hospital care.

Slok AH, Kotz D, van Breukelen G, Chavannes NH, Rutten-van Mölken MP, Kerstjens HA, van der Molen T, Asijee GM, Dekhuijzen PN, Holverda S, Salomé PL, Goossens LM, Twellaar M, In 't Veen JC, van Schayck OC.

BMJ Open. 2016 Jul 11;6(7):e011519. doi: 10.1136/bmjopen-2016-011519.

32.

Diagnosing viral and bacterial respiratory infections in acute COPD exacerbations by an electronic nose: a pilot study.

van Geffen WH, Bruins M, Kerstjens HA.

J Breath Res. 2016 Jun 16;10(3):036001. doi: 10.1088/1752-7155/10/3/036001.

PMID:
27310311
33.

Tiotropium for the treatment of asthma: a drug safety evaluation.

Kerstjens HA, O'Byrne PM.

Expert Opin Drug Saf. 2016 Aug;15(8):1115-24. doi: 10.1080/14740338.2016.1199682. Epub 2016 Jun 20. Review.

PMID:
27279414
34.

Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin Free Base in Non-Cystic Fibrosis Bronchiectasis Patients.

Hoppentocht M, Akkerman OW, Hagedoorn P, Alffenaar JW, van der Werf TS, Kerstjens HA, Frijlink HW, de Boer AH.

PLoS One. 2016 Mar 9;11(3):e0149768. doi: 10.1371/journal.pone.0149768. eCollection 2016.

35.

The Assessment of Burden of COPD (ABC) Scale: A Reliable and Valid Questionnaire.

Slok AH, Bemelmans TC, Kotz D, van der Molen T, Kerstjens HA, In 't Veen JC, Chavannes NH, Asijee GM, Rutten-van Mölken MP, van Schayck OC.

COPD. 2016 Aug;13(4):431-8. doi: 10.3109/15412555.2015.1118025. Epub 2016 Jan 20.

PMID:
26788838
36.

Hyperinflation in COPD exacerbations.

van Geffen WH, Slebos DJ, Kerstjens HA.

Lancet Respir Med. 2015 Dec;3(12):e43-4. doi: 10.1016/S2213-2600(15)00459-2. No abstract available.

PMID:
26679031
37.

Prediction of Long-Term Benefits of Inhaled Steroids by Phenotypic Markers in Moderate-to-Severe COPD: A Randomized Controlled Trial.

Snoeck-Stroband JB, Lapperre TS, Sterk PJ, Hiemstra PS, Thiadens HA, Boezen HM, Ten Hacken NH, Kerstjens HA, Postma DS, Timens W, Sont JK; GLUCOLD Study Group.

PLoS One. 2015 Dec 10;10(12):e0143793. doi: 10.1371/journal.pone.0143793. eCollection 2015.

38.

Endobronchial Valves for Emphysema without Interlobar Collateral Ventilation.

Klooster K, ten Hacken NH, Hartman JE, Kerstjens HA, van Rikxoort EM, Slebos DJ.

N Engl J Med. 2015 Dec 10;373(24):2325-35. doi: 10.1056/NEJMoa1507807.

39.

Cost-Effectiveness of a Community-Based Exercise Programme in COPD Self-Management.

Zwerink M, Effing T, Kerstjens HA, van der Valk P, Brusse-Keizer M, Zielhuis G, van der Palen J.

COPD. 2016;13(2):214-23. doi: 10.3109/15412555.2015.1074171. Epub 2015 Dec 1.

PMID:
26623496
40.

Tiotropium add-on therapy in patients with uncontrolled asthma.

Kerstjens HA, Moroni-Zentgraf P.

Int J Tuberc Lung Dis. 2015 Dec;19(12):1553. doi: 10.5588/ijtld.15.0409. No abstract available.

PMID:
26614202
41.

Current role of anticholinergic drugs in the treatment of asthma: key messages for clinical practice.

Pizzichini MM, Kerstjens HA, Pizzichini E.

Pol Arch Med Wewn. 2015;125(11):859-66. Epub 2015 Oct 30. Review. Erratum in: Pol Arch Med Wewn. 2015;125(12):954.

42.

Determining the Role of Dynamic Hyperinflation in Patients with Severe Chronic Obstructive Pulmonary Disease.

Klooster K, ten Hacken NH, Hartman JE, Sciurba FC, Kerstjens HA, Slebos DJ.

Respiration. 2015;90(4):306-13. doi: 10.1159/000439056. Epub 2015 Sep 10.

43.

Revisiting the Dutch hypothesis.

Postma DS, Weiss ST, van den Berge M, Kerstjens HA, Koppelman GH.

J Allergy Clin Immunol. 2015 Sep;136(3):521-9. doi: 10.1016/j.jaci.2015.06.018. Review.

PMID:
26343936
44.

Anti-inflammatory effects of targeted lung denervation in patients with COPD.

Kistemaker LE, Slebos DJ, Meurs H, Kerstjens HA, Gosens R.

Eur Respir J. 2015 Nov;46(5):1489-92. doi: 10.1183/13993003.00413-2015. Epub 2015 Sep 4. No abstract available.

45.

Bronchodilator reversibility and cardiac considerations with use of tiotropium.

Kerstjens HA, Moroni-Zentgraf P.

Lancet Respir Med. 2015 Aug;3(8):e25-6. doi: 10.1016/S2213-2600(15)00257-X. No abstract available.

PMID:
26282477
46.

Validity and Predictive Value of a Portable Two-Channel Sleep-Screening Tool in the Identification of Sleep Apnea in Patients With Heart Failure.

de Vries GE, van der Wal HH, Kerstjens HA, van Deursen VM, Stegenga B, van Veldhuisen DJ, van der Hoeven JH, van der Meer P, Wijkstra PJ.

J Card Fail. 2015 Oct;21(10):848-55. doi: 10.1016/j.cardfail.2015.06.009. Epub 2015 Jun 19.

PMID:
26095313
47.

Indacaterol vs tiotropium in COPD patients classified as GOLD A and B.

Mahler DA, Kerstjens HA, Donohue JF, Buhl R, Lawrence D, Altman P.

Respir Med. 2015 Aug;109(8):1031-9. doi: 10.1016/j.rmed.2015.05.012. Epub 2015 May 22.

48.

Tiotropium attenuates IL-13-induced goblet cell metaplasia of human airway epithelial cells.

Kistemaker LE, Hiemstra PS, Bos IS, Bouwman S, van den Berge M, Hylkema MN, Meurs H, Kerstjens HA, Gosens R.

Thorax. 2015 Jul;70(7):668-76. doi: 10.1136/thoraxjnl-2014-205731. Epub 2015 May 20.

PMID:
25995156
49.

Tiotropium in asthma - Authors' reply.

Kerstjens HA, Moroni-Zentgraf P, Bateman ED.

Lancet Respir Med. 2015 May;3(5):e17. doi: 10.1016/S2213-2600(15)00105-8. No abstract available.

PMID:
25969363
50.

Increased serum levels of LL37, HMGB1 and S100A9 during exacerbation in COPD patients.

Pouwels SD, Nawijn MC, Bathoorn E, Riezebos-Brilman A, van Oosterhout AJ, Kerstjens HA, Heijink IH.

Eur Respir J. 2015 May;45(5):1482-5. doi: 10.1183/09031936.00158414. No abstract available.

Supplemental Content

Loading ...
Support Center